suPAR: An Inflammatory Mediator for Kidneys.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 265, doi. 10.1159/000524965
- By:
- Publication type:
- Article
Works matching IS 22969381 AND DT 2022 AND VI 8 AND IP 4
Results: 9
1
2
Front & Back Matter.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 1, doi. 10.1159/000525997
- Publication type:
- Article
3
Activated Platelets, the Booster of Chronic Kidney Disease and Cardiovascular Complications.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 297, doi. 10.1159/000525090
- By:
- Publication type:
- Article
4
Association of Immune-Related Genetic and Epigenetic Alterations with Lupus Nephritis.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 286, doi. 10.1159/000524937
- By:
- Publication type:
- Article
5
Deep Learning-Based Model Significantly Improves Diagnostic Performance for Assessing Renal Histopathology in Lupus Glomerulonephritis.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 347, doi. 10.1159/000524880
- By:
- Publication type:
- Article
6
Development and Validation of a Prognostic Nomogram to Predict 30-Day Mortality Risk in Patients with Sepsis-Induced Cardiorenal Syndrome.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 334, doi. 10.1159/000524483
- By:
- Publication type:
- Article
7
Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 275, doi. 10.1159/000524475
- By:
- Publication type:
- Article
8
Treatment of Membranous Nephropathy by Disulfiram through Inhibition of Podocyte Pyroptosis.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 308, doi. 10.1159/000524164
- By:
- Publication type:
- Article
9
Delayed Administration of Nintedanib Ameliorates Fibrosis Progression in CG-Induced Peritoneal Fibrosis Mouse Model.
- Published in:
- Kidney Diseases, 2022, v. 8, n. 4, p. 319, doi. 10.1159/000523852
- By:
- Publication type:
- Article